信州大学HOMEENGLISH交通・キャンパス案内

研究者総覧研究者総覧

研究者、研究内容などで検索
項目別検索はこちら

中嶌岳郎  ナカジマ タケロウ

教員組織学術研究院(医学系)電話番号0263-37-2850
教育組織医学部 医学科 代謝制御学FAX番号0263-37-3094
職名助教メールアドレスnakat@shinshu-u.ac.jp
住所〒390-8621 長野県松本市旭3-1-1ホームページURL

プロフィール

研究分野
生化学
代謝生化学
現在の研究課題
硫酸化糖脂質の生理機能探索
キーワード:sulfatide
多価不飽和脂肪酸の生理機能探索
キーワード:PUFA
所属学会
所属学会
日本脂質生化学会
日本農芸化学会
日本生化学会
学歴
出身大学院
2009 , 信州大学
2005 , 信州大学

出身学校・専攻等(大学院を除く)
2003 , 近畿大学

取得学位
博士(医学) , 信州大学
修士(農学) , 信州大学
研究職歴等
研究職歴
2010- , 現職
2009-2010 , 日本学術振興会 特別研究員PD
2008-2009 , 日本学術振興会 特別研究員DC2

研究活動業績

研究業績(著書・
発表論文等)
著書
疾患モデルの作製と利用-脂質代謝異常と関連疾患<上巻>,第1章転写因子,第5節PPARα
株式会社エル・アイ・シー , :72-81 2015(Jan. 31)
Author:中嶌岳郎,上條祐司,田中直樹,青山俊文


論文
Effects of hypertension and antihypertensive treatments on sulfatide levels in serum and its metabolism
HYPERTENSION RESEARCH,42(5):598-609 2019(May)
Author:Guo, Ran; Hu, Xiao; Yamada, Yosuke; Harada, Makoto; Nakajima, Takero; Kashihara, Toshihide; Yamada, Mitsuhiko; Aoyama, Toshifumi; Kamijo, Yuji;


Impact of chronic kidney dysfunction on serum Sulfatides and its metabolic pathway in mice
GLYCOCONJUGATE JOURNAL,36(1):1-11 2019(Feb.)
Author:Yamada, Yosuke; Harada, Makoto; Hashimoto, Koji; Guo, Ran; Nakajima, Takero; Kashihara, Toshihide; Yamada, Mitsuhiko; Aoyama, Toshifumi; Kamijo, Yuji;


Peroxisome proliferator-activated receptor attenuates high-cholesterol diet-induced toxicity and pro-thrombotic effects in mice
ARCHIVES OF TOXICOLOGY,93(1):149-161 2019(Jan.)
Author:Lu, Yu; Harada, Makoto; Kamijo, Yuji; Nakajima, Takero; Tanaka, Naoki; Sugiyama, Eiko; Kyogashima, Mamoru; Gonzalez, Frank J.; Aoyama, Toshifumi;


Fermentation-induced changes in the concentrations of organic acids, amino acids, sugars, and minerals and superoxide dismutase-like activity in tomato vinegar.
Int. J. Food Prop.,20(4):888-898 2017(Jun.)
Author:Koyama M, Ogasawara Y, Endou K, Akano H, Nakajima T, Aoyama T, Nakamura K.


PPARα protects against trans-fatty-acid-containing diet-induced steatohepatitis.
J Nutr Biochem,39:77-85 2017
Author:Hu X, Tanaka N, Guo R, Lu Y, Nakajima T, Gonzalez FJ, Aoyama T


Decreased fatty acid β-oxidation is the main cause of fatty liver induced by polyunsaturated fatty acid deficiency in mice.
Tohoku J Exp Med,242(3):229-239 2017
Author:Nakajima T, Yang Y, Lu Y, Kamijo Y, Yamada Y, Nakamura K, Koyama M, Yamaguchi S, Sugiyama E, Tanaka N, Aoyama T.


Characterization of bioactive agents in five types of marketed sprouts and comparison of their antihypertensive, antihyperlipidemic, and antidiabetic effects in fructose-loaded SHRs.
J Food Sci Technol,53:581-90 2016
Author:Nakamura K, Koyama M, Ishida R, Kitahara T, Nakajima T, Aoyama T


Age-dependent PPARα activation induces hepatic sulfatide accumulation in transgenic mice carrying the hepatitis C virus core gene.
Glycoconj J,33(6):927-936 2016
Author:Tian Y, Yang Y, Zhang X, Nakajima T, Tanaka N, Sugiyama E, Kamijo Y, Lu Y, Moriya K, Koike K, Gonzalez FJ, Aoyama T.


Peroxisome proliferator-activated receptor α-dependent renoprotection of murine kidney by irbesartan.
Clin Sci,130(21):1969-1981 2016
Author:Harada M, Kamijo Y, Nakajima T, Hashimoto K, Yamada Y, Shimojo H, Gonzalez FJ, Aoyama T.


Activation of PPARα by Fatty Acid Accumulation Enhances Fatty Acid Degradation and Sulfatide Synthesis.
Tohoku J Exp Med,240(2):113-22 2016
Author:Yang Y, Feng Y, Zhang X, Nakajima T, Tanaka N, Sugiyama E, Kamijo Y, Aoyama T.


Steatogenesis in adult-onset type II citrullinemia is associated with down-regulation of PPARα.
Biochim Biophys Acta,1852:473-481 2015
Author:Komatsu M, Kimura T, Yazaki M, Tanaka N, Yang Y, Nakajima T, Horiuchi A, Fang ZZ, Joshita S, Matsumoto A, Umemura T, Tanaka E, Gonzalez FJ, Ikeda S, Aoyama T.


Serum sulfatide abnormality is associated with increased oxidative stress in hemodialysis patients.
Hemodial Int,19:429-438 2015
Author:Yuzhe H, Kamijo Y, Hashimoto K, Harada M, Kanno T, Sugiyama E, Kyogashima M, Oguchi T, Nakajima T, Kanno Y, Aoyama T.


Chronic ethanol consumption decreases serum sulfatide levels by suppressing hepatic cerebroside sulfotransferase expression in mice
Arch Toxicol,88:367-379 2014
Author:Kanbe H, Kamijo Y, Nakajima T, Tanaka N, Sugiyama E, Wang L, Fang ZZ, Hara A, Gonzalez FJ, Aoyama T


One-pot esterification and amidation of phenolic acids
Tetrahedron,70:8097-8107 2014
Author:Nakamura K, Nakajima T, Aoyama T, Okitsu S, Koyama M


Peroxisome proliferator-activated receptor alpha mediates enhancement of gene expression of cerebroside sulfotransferase in several murine organs
GLYCOCONJUGATE JOURNAL,30(6):553-560 2013
Author:Nakajima, T; Kamijo, Y; Huang, YZ; Kimura, T; Tanaka, N; Sugiyama, E; Nakamura, K; Kyogashima, M; Hara, A; Aoyama, T


Purification and identification of antihypertensive peptides from fermented buckwheat sprouts.
J Agric Food Chem,61:3013-3021 2013
Author:Koyama M, Naramoto K, Nakajima T, Aoyama T, Watanabe M, Nakamura K


Attenuation of kidney injuries maintains serum sulfatide levels dependent on hepatic synthetic ability: a possible involvement of oxidative stress.
Tohoku J Exp Med,227:1-12 2012(May)
Author:Sheng X, Nakajima T, Wang L, Zhang X, Kamijo Y, Takahashi K, Tanaka N, Sugiyama E, Kyogashima M, Aoyama T, Hara A.


Long-term improvement of oxidative stress via kidney transplantation ameliorates serum sulfatide levels.
Clin Exp Nephrol,in:press 2012(May)
Author:Kamijo Y, Wang L, Matsumoto A, Nakajima T, Hashimoto K, Higuchi M, Kyogashima M, Aoyama T, Hara A.


Hepatic cerebroside sulfotransferase is induced by PPARalpha activation in mice.
PPAR Res,2012:174932 2012(May)
Author:Kimura T, Nakajima T, Kamijo Y, Tanaka N, Wang L, Hara A, Sugiyama E, Tanaka E, Gonzalez FJ, Aoyama T.


Fatty acid accumulation and resulting PPARalpha activation infibroblasts due to trifunctional protein deficiency.
PPAR Res,2012:371691 2012(May)
Author:Wakabayashi M, Kamijo Y, Nakajima T, Tanaka N, Sugiyama E, Yangyang T, Kimura T, Aoyama T.


PPARalpha activation protects against anti-Thy1 nephritis by suppressing glomerular NF-kappaB signaling.
PPAR Res,2012:976089 2012(May)
Author:Hashimoto K, Kamijo Y, Nakajima T, Harada M, Higuchi M, Ehara T, Shigematsu H, Aoyama T.


Pretreatment by low-dose fibrates protects against acute free fatty acid-induced renal tubule toxicity by counteracting PPARalpha deterioration.
Toxicol Appl Pharmacol,252:237-249 2011
Author:Takahashi K, Kamijo Y, Hora K, Hashimoto K, Higuchi M, Nakajima T, Ehara T, Shigematsu H, Gonzalez FJ, Aoyama T.


Kidney transplantation recovers the reduction level of serum sulfatide in ESRD patients via processes correlated to oxidative stress and platelet count.
Glycoconj J,28:125-135 2011
Author:Wang L, Kamijo Y, Matsumoto A, Nakajima T, Higuchi M, Kannagi R, Kyogashima M, Aoyama T, HaraA.


Effect of bezafibrate on hepatic oxidative stress: comparison between conventional experimental doses and clinically-relevant doses in mice.
Redox Rep,15:123-130 2010(Jun.)
Author:Nakajima T, Tanaka N, Li G, Hu R, Kamijo Y, Hara A, Aoyama T.


Multiple roles of PPARalpha in brown adipose tissue under constitutive and cold conditions.
Genes Cells,15(2):91-100 2010
Author:Komatsu M, Tong Y, Li Y, Nakajima T, Li G, Hu R, Sugiyama E, Kamijo Y, Tanaka N, Hara A, Aoyama T.


Sulfatides are associated with neointimal thickening after vascular injury.
Atherosclerosis,211:291-296 2010
Author:Inoue T, Taguchi I, Abe S, Li G, Hu R, Nakajima T, Hara A, Aoyama T, Kannagi R, Kyogashima M, Node K.


Down-regulation of SREBP-1c is associated with the development of burned-out NASH.
J Hepatol,53:724-731 2010
Author:Nagaya T, Tanaka N, Suzuki T, Sano K, Horiuchi A, Komatsu M, Nakajima T, Nishizawa T, Joshita S, Umemura T, Ichijo T, Matsumoto A, Yoshizawa K, Nakayama J, Tanaka E, Aoyama T.


Eicosapentaenoic acid improves hepatic steatosis independent of PPARalpha activation through inhibition of SREBP-1 maturation in mice.
Biochem Pharmacol,80:1601-1612 2010
Author:Tanaka N, Zhang X, Sugiyama E, Kono H, Horiuchi A, Nakajima T, Kanbe H, Tanaka E, Gonzalez FJ, Aoyama T.


Acute kidney injury induced by protein-overload nephropathy down-regulates gene expression of hepatic cerebroside sulfotransferase in mice, resulting in reduction of liver and serum sulfatides.
Biochem Biophys Res Commun,390:1382-1388 2009(Dec.)
Author:Zhang X, Nakajima T, Kamijo Y, Li G, Hu R, Kannagi R, Kyogashima M, Aoyama T, Hara A.


Bezafibrate at clinically relevant doses decreases serum/liver triglycerides via down-regulation of sterol regulatory element-binding protein-1c in mice: a novel peroxisome proliferator-activated receptor alpha-independent mechanism.
Mol Pharmacol,75:782-792 2009(Apr.)
Author:Nakajima T, Tanaka N, Kanbe H, Hara A, Kamijo Y, Zhang X, Gonzalez FJ, Aoyama T.


Kidney dysfunction induced by protein overload nephropathy reduces serum sulfatide levels in mice.
Nephrology,14(7):658-662 2009
Author:Li G, Hu R, Kamijo Y, Nakajima T, Aoyama T, Ehara T, Shigematsu H, Kannagi R, Kyogashima M, Hara A.


Cholesterol-lowering effect of bezafibrate is independent of peroxisome proliferator-activated receptor activation in mice.
Biochem Pharmacol,76:108-119 2008(Jul.)
Author:Nakajima T, Tanaka N, Sugiyama E, Kamijo Y, Hara A, Hu R, Li G, Li Y, Nakamura K, Gonzalez FJ, Aoyama T.


Establishment of a quantitative, qualitative, and high-throughput analysis of sulfatides from small amounts of sera by matrix-assisted laser desorption ionization-time of flight mass spectrometry.
Anal Biochem,362:1-7 2007
Author:Li G, Hu R, Kamijo Y, Nakajima T, Aoyama T, Inoue T, Node K, Kannagi R, Kyogashima M, Hara A.


Serum sulfatides as a novel biomarker for cardiovascular disease in patients with end-stage renal failure.
Glycoconj J,24:565-571 2007
Author:Hu R, Li G, Kamijo Y, Aoyama T, Nakajima T, Inoue T, Node K, Kannagi R, Kyogashima M, Hara A.


Peroxisome proliferator-activated receptor alpha-independent peroxisome proliferation.
Biochem Biophys Res Commun,346:1307-1311 2006
Author:Zhang X, Tanaka N, Nakajima T, Kamijo Y, Gonzalez FJ, Aoyama T.


Base-labile tert-butoxycarbonyl (Boc) group on phenols.
Tetrahedron Lett,45:495-499 2004
Author:Nakamura K, Nakajima T, Kayahara H, Nomura E, Taniguchi H.